NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...
The Texas Vaccine Policy Symposium, hosted by Rice University’s Baker Institute for Public Policy Nov. 15, will discuss the impact of vaccines in Texas and the challenges ahead as experts look toward ...
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- DIOSynVax, a clinical-stage biotechnology company specializing in AI-leveraged vaccines has used this innovative technology to develop a pan-bird-flu ...
A nurse prepares children for a polia vaccine shot as part of a city-wide testing of the vaccine on elementary school students. As students across the country shoulder backpacks and file into ...
A short educational session on the human papillomavirus (HPV) vaccine improved vaccination willingness among women with autoimmune rheumatic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results